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Background: In March 2020 formally declared pandemic of coronavirus disease (COVID-19) caused a 
global impact on public health. Venous thromboembolism (VTE) encompassing pulmonary embolism 
(PE) and deep venous thrombosis (DVT) is frequently observed in patients with COVID-191, while the 
pandemic influence on non COVID-19 VTE prevalence remains unknown. Previous meta -analysis 
supported an association between regular physical activity and lower risk of VTE when compared with 
a sedentary or less active lifestyle2. Aim: to investigate the influence of pandemic circumstances on 
the prevalence of non COVID-19 patients hospitalized due to VTE. 
Patients and Methods: Single centre retrospective analysis of consecutive non COVID-19 patients ad-
mitted for VTE was performed. We compared demographic characteristics and diagnostics findings in 
patients hospitalized for VTE between 1st of March and 31st of October 2019 and non COVID-19 VTE pa-
tients hospitalized between the same period in 2020. All patients underwent laboratory tests, venous 
ultrasonography of the lower limbs and/or CT pulmonary angiography and had negative swab test for 
SARS-CoV2 at admission. One patient had previously recovered from COVID-19. 
Results: During the period of 8 months 70 VTE patients (female 48 %, mean age 60.8 ± 17.2 years) were 
admitted in 2019, while 86 non COVID-19 VTE patients (female 50 %, mean age 68.5± 16.8 years) were ad-
mitted in 2020. There was no significant difference in prevalence of VTE hospitalization (4.1 % vs 5.4%, 
p=0.106), but patients in 2020 were significantly older (p=0.002). Dividing the VTE cases into isolated PE, 
isolated DVT and combined DVT+PE we found a significant increase in prevalence of DVT+PE during 
pandemic (34 vs 36, p=0.23; 23 vs 25, p=0.24 and 13 vs 25, p=0.03, respectively). 
Conclusion: During COVID 19 pandemic we observed significant increase in prevalence of hospital-
ized non COVID-19 patients with combined DVT+ PE but not with isolated PE or isolated DVT. Possible 
explanation could be a less active lifestyle due to pandemic social restriction recommendation and 
delaying treatment for initial DVT. 
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